These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 21266809
1. Gastrointestinal bleeding after percutaneous coronary intervention. Tanigawa T, Watanabe T, Nadatani Y, Otani K, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Arakawa T. Digestion; 2011; 83(3):153-60. PubMed ID: 21266809 [Abstract] [Full Text] [Related]
2. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis. Dai X, Makaryus AN, Makaryus JN, Jauhar R. Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228 [Abstract] [Full Text] [Related]
4. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Aronow HD, Steinhubl SR, Brennan DM, Berger PB, Topol EJ, CREDO Investigators. Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647 [Abstract] [Full Text] [Related]
8. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries. Motovska Z, Kala P. Clin Ther; 2008 Feb; 30 Pt 2():2191-202. PubMed ID: 19281914 [Abstract] [Full Text] [Related]
9. Management of patients with high gastrointestinal risk on antiplatelet therapy. Cryer B. Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259 [Abstract] [Full Text] [Related]
12. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment. Hsu PI. J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743 [Abstract] [Full Text] [Related]
13. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan. Nadatani Y, Watanabe T, Tanigawa T, Sogawa M, Yamagami H, Shiba M, Watanabe K, Tominaga K, Fujiwara Y, Yoshiyama M, Arakawa T. Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342 [Abstract] [Full Text] [Related]
14. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization. Gao P, Xiong H, Zheng Z, Li L, Gao R, Hu SS. Platelets; 2010 Mar; 21(3):183-90. PubMed ID: 20201634 [Abstract] [Full Text] [Related]
16. Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now? Liberopoulos EN, Elisaf MS, Tselepis AD, Archimandritis A, Kiskinis D, Cokkinos D, Mikhailidis DP. Platelets; 2006 Feb; 17(1):1-6. PubMed ID: 16308180 [Abstract] [Full Text] [Related]
17. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents. Spinler SA. Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808 [Abstract] [Full Text] [Related]
18. Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention. Hiew C, Duggan A, de Malmanche T, Hatton R, Baker F, Attia J, Collins N. Intern Med J; 2012 Mar; 42(3):289-93. PubMed ID: 20492005 [Abstract] [Full Text] [Related]
19. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation. Luinstra M, Naunton M, Peterson GM, Bereznicki L. J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741 [Abstract] [Full Text] [Related]